Candriam S.C.A. Lowers Holdings in Mettler-Toledo International, Inc. $MTD

Candriam S.C.A. trimmed its holdings in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 21.8% during the 1st quarter, HoldingsChannel.com reports. The firm owned 21,458 shares of the medical instruments supplier’s stock after selling 5,978 shares during the quarter. Candriam S.C.A.’s holdings in Mettler-Toledo International were worth $27,063,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Allworth Financial LP grew its stake in shares of Mettler-Toledo International by 6.1% during the 3rd quarter. Allworth Financial LP now owns 121 shares of the medical instruments supplier’s stock valued at $149,000 after purchasing an additional 7 shares during the period. Evergreen Capital Management LLC raised its stake in Mettler-Toledo International by 4.5% during the 4th quarter. Evergreen Capital Management LLC now owns 184 shares of the medical instruments supplier’s stock valued at $257,000 after purchasing an additional 8 shares during the period. Meridian Wealth Management LLC raised its position in shares of Mettler-Toledo International by 1.7% during the fourth quarter. Meridian Wealth Management LLC now owns 488 shares of the medical instruments supplier’s stock valued at $680,000 after buying an additional 8 shares during the last quarter. EverSource Wealth Advisors LLC grew its position in shares of Mettler-Toledo International by 2.7% during the fourth quarter. EverSource Wealth Advisors LLC now owns 302 shares of the medical instruments supplier’s stock valued at $421,000 after purchasing an additional 8 shares in the last quarter. Finally, Values First Advisors Inc. raised its holdings in shares of Mettler-Toledo International by 1.3% during the 1st quarter. Values First Advisors Inc. now owns 625 shares of the medical instruments supplier’s stock worth $789,000 after acquiring an additional 8 shares in the last quarter. 95.07% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on MTD shares. Barclays reduced their price objective on Mettler-Toledo International from $1,550.00 to $1,500.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 14th. Morgan Stanley decreased their price objective on Mettler-Toledo International from $1,475.00 to $1,275.00 and set an “equal weight” rating for the company in a report on Tuesday, May 12th. Wolfe Research assumed coverage on Mettler-Toledo International in a research report on Tuesday, June 2nd. They set a “peer perform” rating on the stock. Wall Street Zen lowered shares of Mettler-Toledo International from a “buy” rating to a “hold” rating in a research note on Saturday, May 16th. Finally, JPMorgan Chase & Co. cut their price objective on shares of Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating on the stock in a report on Monday, May 11th. Six equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $1,408.55.

Mettler-Toledo International Stock Performance

Mettler-Toledo International stock traded up $8.51 during midday trading on Friday, hitting $1,296.53. 106,818 shares of the company were exchanged, compared to its average volume of 205,615. The business has a fifty day simple moving average of $1,177.49 and a two-hundred day simple moving average of $1,286.27. The firm has a market capitalization of $26.20 billion, a PE ratio of 30.41, a price-to-earnings-growth ratio of 2.70 and a beta of 1.24. Mettler-Toledo International, Inc. has a fifty-two week low of $1,023.05 and a fifty-two week high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings data on Thursday, May 7th. The medical instruments supplier reported $8.91 EPS for the quarter, topping analysts’ consensus estimates of $8.70 by $0.21. Mettler-Toledo International had a net margin of 21.40% and a negative return on equity of 622.80%. The business had revenue of $947.13 million for the quarter, compared to analysts’ expectations of $943.14 million. During the same quarter last year, the company earned $8.19 EPS. The business’s revenue was up 7.2% on a year-over-year basis. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. As a group, equities analysts expect that Mettler-Toledo International, Inc. will post 46.6 earnings per share for the current year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.